TXNIP-IN-1_product_DataBase

Bioactivity

TXNIP-IN-1 is TXNIP-TRX (thioredoxin-interacting protein- thioredoxin) complex inhibitor extracted from patent US20200085800A1, Compound 1. TXNIP-IN-1 can be used in the research of TXNIP-TRX complex associated metabolic disorder (diabetes), cardiovascular disease, or inflammatory disease[1].

Target

TXNIP-TRX complex

Invitro

TXNIP-IN-1 bocks high glucose (HG induced) TXNIP-TRX complex formation[1].TXNIP-IN-1 (1.25-5 μM) reduces HG-induced expression of TNF in monocytes[1].TXNIP-IN-1 (1.25-5 μM; 72 hours) inhibits TXNIP mRNA expression in THP1 cells[1].TXNIP-IN-1 (0.3-10 μM; 72 hours) inhibits TXNIP mRNA expression in murine RAW macrophages[1].TXNIP-IN-1 (5-20 μM; 72 hours) decreases TXNIP but not TNF-alpha mRNA levels in MIN6 cells[1].TXNIP-IN-1 (0.62-5 μM; 72 hours) affects TXNIP and TNF-alpha mRNA expression in human pancreas 1.1B4 beta cells[1].TXNIP-IN-1 (5 μM; 16-72 hours) inhibits c-TRX interaction in THP1 cells cultured in 25mM glucose[1].TXNIP-IN-1 targets TXNIP mRNA in human pancreatic islets[1].

Name

TXNIP-IN-1

CAS

1268955-50-5

Formula

C12H12N2O4

Molar Mass

248.23

Appearance

Solid

Transport

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Reference

[1]. Rama Natarajan, et al. Txnip-trx complex inhibitors and methods of using the same. US20200085800A1.

PeptideDB

TXNIP-IN-1

CAS: 1268955-50-5 F: C12H12N2O4 W: 248.23